Sun Pharma Industries Ltd. obtained FDA approval for Abbreviated New Drug Application 085868, marking a key regulatory advancement for a new generic product. This clearance is expected to contribute to the company's future earnings and strengthen its commercial footprint in the pharmaceutical sector.